brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastische mittel - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).
blissel 50 µg/g vaginalgel
italfarmaco - estriol - vaginalgel - 50 µg/g - estriol 50 µg/g - estriol
treclinax 10 mg/g - 0,25 mg/g gel
mylan epd - clindamycin-phosphat; tretinoin - gel - 10 mg/g - 0,25 mg/g - clindamycin-phosphat 12 mg/g; tretinoin 0.25 mg/g - clindamycin, combinations
blissel 50 mikrogramm/g vaginalgel
italfarmaco s.a. - estriol -
lamisil 1 % dermgel, gel
gsk-gebro consumer healthcare gmbh - terbinafin - terbinafin
elymbus 0,1 mg/g augengel im einzeldosisbehältnis
laboratoires thea s.a.s. - bimatoprost -
elymbus 0,1 mg/g augengel im einzeldosisbehältnis
laboratoires théa s.a.s. (3229973) - augengel im einzeldosisbehältnis - 0,1 mg/g
aknadue 1 mg/g - 25 mg/g gel